161 related articles for article (PubMed ID: 24776932)
1. Impact of serum high mobility group box 1 and soluble receptor for advanced glycation end-products on subclinical atherosclerosis in patients with granulomatosis with polyangiitis.
Souza AW; de Leeuw K; van Timmeren MM; Limburg PC; Stegeman CA; Bijl M; Westra J; Kallenberg CG
PLoS One; 2014; 9(4):e96067. PubMed ID: 24776932
[TBL] [Abstract][Full Text] [Related]
2. Effects of atorvastatin on serum soluble receptors for advanced glycation end-products in type 2 diabetes.
Tam HL; Shiu SW; Wong Y; Chow WS; Betteridge DJ; Tan KC
Atherosclerosis; 2010 Mar; 209(1):173-7. PubMed ID: 19733353
[TBL] [Abstract][Full Text] [Related]
3. Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins.
Santilli F; Bucciarelli L; Noto D; Cefalù AB; Davì V; Ferrante E; Pettinella C; Averna MR; Ciabattoni G; Davì G
Free Radic Biol Med; 2007 Nov; 43(9):1255-62. PubMed ID: 17893038
[TBL] [Abstract][Full Text] [Related]
4. Statins attenuate high mobility group box-1 protein induced vascular endothelial activation : a key role for TLR4/NF-κB signaling pathway.
Yang J; Huang C; Yang J; Jiang H; Ding J
Mol Cell Biochem; 2010 Dec; 345(1-2):189-95. PubMed ID: 20714791
[TBL] [Abstract][Full Text] [Related]
5. Soluble receptor for advanced glycation end-products and progression of airway disease.
Iwamoto H; Gao J; Pulkkinen V; Toljamo T; Nieminen P; Mazur W
BMC Pulm Med; 2014 Apr; 14():68. PubMed ID: 24758342
[TBL] [Abstract][Full Text] [Related]
6. Effects of atorvastatin on progression of diabetic nephropathy and local RAGE and soluble RAGE expressions in rats.
Lu L; Peng WH; Wang W; Wang LJ; Chen QJ; Shen WF
J Zhejiang Univ Sci B; 2011 Aug; 12(8):652-9. PubMed ID: 21796806
[TBL] [Abstract][Full Text] [Related]
7. Placental growth factor, pregnancy-associated plasma protein-A, soluble receptor for advanced glycation end products, extracellular newly identified receptor for receptor for advanced glycation end products binding protein and high mobility group box 1 levels in patients with acute kidney injury: a cross sectional study.
Zakiyanov O; Kriha V; Vachek J; Zima T; Tesar V; Kalousova M
BMC Nephrol; 2013 Nov; 14():245. PubMed ID: 24188108
[TBL] [Abstract][Full Text] [Related]
8. Increased levels of soluble receptor for advanced glycation end products (sRAGE) and high mobility group box 1 (HMGB1) are associated with death in patients with acute respiratory distress syndrome.
Nakamura T; Sato E; Fujiwara N; Kawagoe Y; Maeda S; Yamagishi S
Clin Biochem; 2011 Jun; 44(8-9):601-4. PubMed ID: 21211520
[TBL] [Abstract][Full Text] [Related]
9. Simvastatin suppresses vascular inflammation and atherosclerosis in ApoE(-/-) mice by downregulating the HMGB1-RAGE axis.
Liu M; Yu Y; Jiang H; Zhang L; Zhang PP; Yu P; Jia JG; Chen RZ; Zou YZ; Ge JB
Acta Pharmacol Sin; 2013 Jun; 34(6):830-6. PubMed ID: 23564080
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of high mobility group box-1 protein (HMGB1) and soluble receptors of advanced glycation end-products (RAGE) in depressed patients treated with electroconvulsive therapy.
Abe H; Okada-Tsuchioka M; Kajitani N; Omori W; Itagaki K; Shibasaki C; Boku S; Matsuhisa T; Takebayashi M
Neuropsychopharmacol Rep; 2023 Sep; 43(3):359-364. PubMed ID: 37337402
[TBL] [Abstract][Full Text] [Related]
11. Plasma concentrations of high-mobility group box protein 1, soluble receptor for advanced glycation end-products and circulating DNA in patients with acute pancreatitis.
Kocsis AK; Szabolcs A; Hofner P; Takács T; Farkas G; Boda K; Mándi Y
Pancreatology; 2009; 9(4):383-91. PubMed ID: 19451748
[TBL] [Abstract][Full Text] [Related]
12. Higher levels of the soluble receptor for advanced glycation end products and lower levels of the extracellular newly identified receptor for advanced glycation end products were associated with lipid-lowering drugs in patients with type 1 diabetes: a comparative cross-sectional study.
Melin EO; Dereke J; Hillman M
Lipids Health Dis; 2020 Oct; 19(1):223. PubMed ID: 33054750
[TBL] [Abstract][Full Text] [Related]
13. In vitro effects of atorvastatin on lipopolysaccharide-induced gene expression in endometriotic stromal cells.
Sharma I; Dhawan V; Mahajan N; Saha SC; Dhaliwal LK
Fertil Steril; 2010 Oct; 94(5):1639-46.e1. PubMed ID: 19944411
[TBL] [Abstract][Full Text] [Related]
14. Functional role of soluble receptor for advanced glycation end products in stroke.
Tang SC; Wang YC; Li YI; Lin HC; Manzanero S; Hsieh YH; Phipps S; Hu CJ; Chiou HY; Huang YS; Yang WS; Mattson MP; Arumugam TV; Jeng JS
Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):585-94. PubMed ID: 23288172
[TBL] [Abstract][Full Text] [Related]
15. Serum soluble receptor for advanced glycation end products levels and aortic augmentation index in early rheumatoid arthritis--a prospective study.
Tam LS; Shang Q; Li EK; Wong S; Li RJ; Lee KL; Leung YY; Ying KY; Yim CW; Kun EW; Leung MH; Li M; Li TK; Zhu TY; Chui RK; Tseung L; Yu SL; Kuan WP; Yu CM
Semin Arthritis Rheum; 2013 Feb; 42(4):333-45. PubMed ID: 22920235
[TBL] [Abstract][Full Text] [Related]
16. Atorvastatin protects rat brains against permanent focal ischemia and downregulates HMGB1, HMGB1 receptors (RAGE and TLR4), NF-kappaB expression.
Wang L; Zhang X; Liu L; Yang R; Cui L; Li M
Neurosci Lett; 2010 Mar; 471(3):152-6. PubMed ID: 20100543
[TBL] [Abstract][Full Text] [Related]
17. Simvastatin and atorvastatin attenuate VCAM-1 and uPAR expression on human endothelial cells and platelet surface expression of CD40 ligand.
Stach K; Nguyen XD; Lang S; Elmas E; Weiss C; Borggrefe M; Fischer J; Kälsch T
Cardiol J; 2012; 19(1):20-8. PubMed ID: 22298164
[TBL] [Abstract][Full Text] [Related]
18. The interface of inflammation and subclinical atherosclerosis in granulomatosis with polyangiitis (Wegener's): a preliminary study.
Hajj-Ali RA; Major J; Langford C; Hoffman GS; Clark T; Zhang L; Sun Z; Silverstein RL
Transl Res; 2015 Oct; 166(4):366-74. PubMed ID: 26024800
[TBL] [Abstract][Full Text] [Related]
19. The presence of high mobility group box-1 and soluble receptor for advanced glycation end-products in juvenile idiopathic arthritis and juvenile systemic lupus erythematosus.
Bobek D; Grčević D; Kovačić N; Lukić IK; Jelušić M
Pediatr Rheumatol Online J; 2014; 12():50. PubMed ID: 25516724
[TBL] [Abstract][Full Text] [Related]
20. Markers of inflammation, thrombosis and endothelial activation correlate with carotid IMT regression in stable coronary disease after atorvastatin treatment.
Baldassarre D; Porta B; Camera M; Amato M; Arquati M; Brusoni B; Fiorentini C; Montorsi P; Romano S; Veglia F; Tremoli E; Cortellaro M;
Nutr Metab Cardiovasc Dis; 2009 Sep; 19(7):481-90. PubMed ID: 19171469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]